Literature DB >> 19454095

Malaria: severe, life-threatening.

Aika Amy Anita Omari1, Paul Garner.   

Abstract

INTRODUCTION: Severe malaria mainly affects children under 5 years old, non-immune travellers, migrants to malarial areas, and people living in areas with unstable or seasonal malaria. Cerebral malaria, causing encephalopathy and coma, is fatal in around 20% of children and adults, and neurological sequelae may occur in some survivors. Severe malarial anaemia may have a mortality rate of over 13%. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of antimalarial treatments; and adjunctive treatment for complicated falciparum malaria in non-pregnant people? We searched: Medline, Embase, The Cochrane Library and other important databases up to December 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 31 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: dexamethasone, exchange blood transfusion, initial blood transfusion, intramuscular artemether, intravenous artesunate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19454095      PMCID: PMC2943816     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  29 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

Review 2.  Malaria resistance genes: a natural selection.

Authors:  A V Hill
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 May-Jun       Impact factor: 2.184

3.  Reduction of coma by quinine loading dose in falciparum cerebral malaria.

Authors:  J J Fargier; F J Louis; M Cot; B Maubert; C Hounsinou; J P Louis; J Le Bras; J E Touze
Journal:  Lancet       Date:  1991-10-05       Impact factor: 79.321

4.  Treatment of severe malaria by exchange transfusion.

Authors: 
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

5.  Comparison of rectal artemisinin with intravenous quinine in the treatment of severe malaria in Ethiopia.

Authors:  Y Birku; E Makonnen; A Bjorkman
Journal:  East Afr Med J       Date:  1999-03

6.  WHO Expert Committee on Malaria.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

7.  Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial.

Authors:  Jane Ruth Aceng; Justus S Byarugaba; James K Tumwine
Journal:  BMJ       Date:  2005-02-12

8.  Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria.

Authors:  T T Hien; K Arnold; H Vinh; B M Cuong; N H Phu; T T Chau; N T Hoa; L V Chuong; N T Mai; N N Vinh
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

9.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

10.  Quinine loading dose in severe Falciparum malaria at Kenyatta National Hospital, Kenya.

Authors:  M Tombe; K M Bhatt; A O Obel
Journal:  East Afr Med J       Date:  1992-12
View more
  1 in total

1.  Removal of malaria-infected red blood cells using magnetic cell separators: A computational study.

Authors:  Jeongho Kim; Mehrdad Massoudi; James F Antaki; Alberto Gandini
Journal:  Appl Math Comput       Date:  2012-02-15       Impact factor: 4.091

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.